Get my own profile
Public access
View all20 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Daniel G. AndersonMassachusetts Institute of TechnologyVerified email at mit.edu
- Robert LangerDavid H. Koch Institute Professor, MITVerified email at mit.edu
- J. Robert DorkinMITVerified email at mit.edu
- Kevin KauffmanAssociate Director, Orna TherapeuticsVerified email at mit.edu
- Jason L. AndresenPhD Candidate, MITVerified email at mit.edu
- James KaczmarekAssociate Director at ReCode TherapeuticsVerified email at recodetx.com
- Mark W. TibbittAssociate Professor of Macromolecular Engineering, ETH ZurichVerified email at ethz.ch
- Eric A. AppelProfessor of Materials Science & Engineering, Stanford UniversityVerified email at stanford.edu
- Michael J. MitchellAssociate Professor of Bioengineering, University of PennsylvaniaVerified email at seas.upenn.edu
- Marion PaoliniMITVerified email at mit.edu
- MATTHIAS A OBERLIXibus SystemsVerified email at mit.edu
- Faryal MirInternal Medicine Resident, KPC HealthVerified email at kpc.health
- Bianca SculimbreneAssociate Professor, College of the Holy CrossVerified email at holycross.edu
- delai chenGSK VaccinesVerified email at uchicago.edu
- Volkan Yesilyurt, Ph.D.Takeda PharmaceuticalsVerified email at takeda.com
- Karsten OlejnikSigilon TherapeuticsVerified email at sigilon.com
- Dr. Asha K. PatelAssistant Professor at Imperial College LondonVerified email at mit.edu
- Matthew J. WebberKeating-Crawford Collegiate Professor; Chemical & Biomolecular Engineering; Notre DameVerified email at nd.edu
- Katy N Newlin (Olafson)MIT Koch Institute for Integrative Cancer ResearchVerified email at mit.edu
- Andreas M ReichmuthUniversity of ZurichVerified email at uzh.ch
Follow
Owen S. Fenton
Assistant Professor of Pharmacy, University of North Carolina at Chapel Hill
Verified email at unc.edu - Homepage